|
[1] SIEGEL RL, MILLER KD, JEMAL A. Cancer statistics, 2019[J].CA Cancer J Clin, 2019, 69(1):7-34.
|
|
[2] TEMPERO MA, MALAFA MP, CHIOREAN EG, et al. Pancreatic adenocarcinoma, version 1. 2019[J]. J Natl Compr Canc Netw, 2019, 17(3):202-210.
|
|
[3] BASSI C, MARCHEGIANI G, DERVENIS C, et al. The 2016 update of the International Study Group(ISGPS)definition and grading of postoperative pancreatic fistula:11 Years After[J].Surgery, 2017, 161(3):584-591.
|
|
[4] NAKAMURA T, HIRANO S, NOJI T, et al. Distal pancreatectomy with en bloc celiac axis resection(modified appleby procedure)for locally advanced pancreatic body cancer:A single-center review of 80 consecutive patients[J]. Ann Surg Oncol, 2016, 23(Suppl 5):969-975.
|
|
[5] KLOMPMAKER S, PETERS NA, van HILST J, et al. Outcomes and risk score for distal pancreatectomy with celiac axis resection(DP-CAR):An international multicenter analysis[J].Ann Surg Oncol, 2019, 26(3):772-781.
|
|
[6] YAMAMOTO T, SATOI S, KAWAI M, et al. Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic ductal adenocarcinoma?-Multicenter surgical group study[J]. Pancreatology, 2018, 18(1):106-113.
|
|
[7] YAMAGUCHI K, NAKANO K, KOBAYASHI K, et al. Appleby operation for pancreatic body-tail carcinoma:Report of three cases[J]. Surg Today, 2003, 33(11):873-878.
|
|
[8] TAKAHASHI Y, KANEOKA Y, MAEDA A, et al. Distal pancreatectomy with celiac axis resection for carcinoma of the body and tail of the pancreas[J]. World J Surg, 2011, 35(11):2535-2542.
|
|
[9] BONDS M, ROCHA FG. Contemporary review of borderline resectable pancreatic ductal adenocarcinoma[J]. J Clin Med,2019, 8(8):e1205.
|
|
[10] YOSHIYA S, FUKUZAWA K, INOKUCHI S, et al. Efficacy of neoadjuvant chemotherapy in distal pancreatectomy with en bloc celiac axis resection(DP-CAR)for locally advanced pancreatic cancer[J]. J Gastrointest Surg, 2019.[Online ahead of print]
|
|
[11] PETERS NA, JAVED AA, CAMERON JL, et al. Modified appleby procedure for pancreatic adenocarcinoma:Does improved neoadjuvant therapy warrant such an aggressive approach?[J]. Ann Surg Oncol, 2016, 23(11):3757-3764.
|
|
[12] KLUGER MD, RASHID MF, ROSARIO VL, et al. Resection of locally advanced pancreatic cancer without regression of arterial encasement after modern-era neoadjuvant therapy[J]. J Gastrointest Surg, 2018, 22(2):235-241.
|
|
[13] KLOMPMAKER S, van HILST J, GERRITSEN SL, et al. Outcomes after distal pancreatectomy with celiac axis resection for pancreatic cancer:A pan-European retrospective cohort study[J]. Ann Surg Oncol, 2018, 25(5):1440-1447.
|
|
[14] OCUIN LM, MILLER-OCUIN JL, NOVAK SM, et al. Robotic and open distal pancreatectomy with celiac axis resection for locally advanced pancreatic body tumors:A single institutional assessment of perioperative outcomes and survival[J]. HPB(Oxford), 2016, 18(10):835-842.
|
|
[15] YOSHITOMI H, SAKAI N, KAGAWA S, et al. Feasibility and safety of distal pancreatectomy with en bloc celiac axis resection(DP-CAR)combined with neoadjuvant therapy for borderline resectable and unresectable pancreatic body/tail cancer[J]. Langenbecks Arch Surg, 2019, 404(4):451-458.
|
DownLoad: